PubRank

Thomas F Tedder

Author PubWeight™ 189.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008 6.73
2 Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008 5.85
3 B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011 5.16
4 Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009 4.45
5 B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005 4.31
6 Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2010 4.28
7 B lymphocytes: how they develop and function. Blood 2008 4.07
8 Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008 3.67
9 IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 2011 3.61
10 The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy. J Exp Med 2004 3.56
11 Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012 3.48
12 B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 2010 3.07
13 B-lymphocyte contributions to human autoimmune disease. Immunol Rev 2008 2.89
14 The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009 2.87
15 Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning. Blood 2012 2.86
16 Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci U S A 2007 2.81
17 B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010 2.79
18 Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol 2008 2.45
19 Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol 2010 2.44
20 The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J Immunol 2005 2.16
21 CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat Immunol 2004 2.16
22 CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 2009 2.15
23 CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies. Blood 2010 2.06
24 B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J Immunol 2007 2.05
25 Mouse CD20 expression and function. Int Immunol 2004 2.02
26 Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 2010 1.98
27 B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J Immunol 2008 1.96
28 Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy. J Exp Med 2006 1.80
29 B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice. J Immunol 2010 1.77
30 Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004 1.70
31 IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther 2013 1.66
32 B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol 2006 1.64
33 CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest 2002 1.61
34 Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J Immunol 2010 1.61
35 Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV. Blood 2008 1.55
36 Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J Exp Med 2011 1.53
37 CD83 expression influences CD4+ T cell development in the thymus. Cell 2002 1.52
38 New prospects for autoimmune disease therapy: B cells on deathwatch. Arthritis Rheum 2006 1.51
39 Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J Clin Invest 2011 1.50
40 Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 2002 1.50
41 Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation. J Leukoc Biol 2013 1.48
42 Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood 2007 1.48
43 Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice. Blood 2009 1.46
44 B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med 2013 1.43
45 Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity 2003 1.42
46 Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol 2011 1.40
47 Identifying regulatory B cells (B10 cells) that produce IL-10 in mice. Methods Mol Biol 2011 1.39
48 CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo. J Immunol 2006 1.37
49 L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes. J Exp Med 2003 1.32
50 IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol 2011 1.29
51 Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am J Pathol 2006 1.28
52 CD molecules 2005: human cell differentiation molecules. Blood 2005 1.27
53 CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol 2008 1.23
54 B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice. Immunology 2007 1.22
55 B10 cell regulation of health and disease. Immunol Rev 2014 1.21
56 The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment. J Immunol 2003 1.21
57 CD19 expression in B cells is important for suppression of contact hypersensitivity. Am J Pathol 2007 1.20
58 Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis. Mol Immunol 2004 1.20
59 CD19 regulates innate immunity by the toll-like receptor RP105 signaling in B lymphocytes. Blood 2003 1.18
60 CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo. J Immunol 2007 1.15
61 Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease. Proc Natl Acad Sci U S A 2005 1.15
62 Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. J Immunol 2007 1.13
63 Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One 2011 1.13
64 L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity. J Immunol 2003 1.09
65 B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody. J Pharmacol Exp Ther 2010 1.09
66 Isolation and generation of human dendritic cells. Curr Protoc Immunol 2012 1.08
67 Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol 2010 1.07
68 CD25+CD4+ regulatory T cell migration requires L-selectin expression: L-selectin transcriptional regulation balances constitutive receptor turnover. J Immunol 2007 1.03
69 Regulatory B cell (B10 Cell) expansion during Listeria infection governs innate and cellular immune responses in mice. J Immunol 2012 1.03
70 B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse. Am J Pathol 2004 1.02
71 Dendritic cell CD83: a therapeutic target or innocent bystander? Immunol Lett 2007 1.02
72 A new twist to the leukocyte adhesion cascade: intimate cooperation is key. Trends Immunol 2005 1.01
73 Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease. Blood 2013 0.99
74 Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts. Blood 2003 0.99
75 Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement. J Immunol 2005 0.99
76 A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice. J Immunol 2012 0.99
77 B lymphocytes differentially influence acute and chronic allograft rejection in mice. J Immunol 2011 0.98
78 CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. Int Immunol 2007 0.98
79 CD83: a regulatory molecule of the immune system with great potential for therapeutic application. J Med Dent Sci 2006 0.97
80 CD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse model. Arthritis Rheum 2008 0.96
81 Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background. J Immunol 2004 0.96
82 Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis. Arthritis Rheum 2004 0.95
83 Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J Immunol 2004 0.95
84 Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction. J Immunol 2002 0.95
85 CD21/35 promotes protective immunity to Streptococcus pneumoniae through a complement-independent but CD19-dependent pathway that regulates PD-1 expression. J Immunol 2009 0.95
86 A functional role for circulating mouse L-selectin in regulating leukocyte/endothelial cell interactions in vivo. J Immunol 2002 0.94
87 CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions. J Immunol 2010 0.94
88 Endothelial selectins regulate skin wound healing in cooperation with L-selectin and ICAM-1. J Leukoc Biol 2007 0.94
89 B lymphocytes contribute to autoimmune disease pathogenesis: current trends and clinical implications. Autoimmun Rev 2003 0.93
90 CD22 and Siglec-G in B cell function and tolerance. Trends Immunol 2012 0.93
91 Relative contributions of selectins and intercellular adhesion molecule-1 to tissue injury induced by immune complex deposition. Am J Pathol 2003 0.93
92 The cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and L-selectin expression. J Immunol 2002 0.92
93 Role of the CD19 and CD21/35 receptor complex in innate immunity, host defense and autoimmunity. Adv Exp Med Biol 2005 0.92
94 B-lymphocyte effector functions in health and disease. Immunol Res 2011 0.92
95 CD22 regulates time course of both B cell division and antibody response. J Immunol 2008 0.91
96 Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice. J Immunol 2007 0.91
97 B cells contribute to ischemia/reperfusion-mediated tissue injury. J Autoimmun 2009 0.90
98 B cell antigen receptor and CD40 differentially regulate CD22 tyrosine phosphorylation. J Immunol 2006 0.90
99 Regulatory B cells that produce IL-10: a breath of fresh air in allergic airway disease. J Allergy Clin Immunol 2010 0.90
100 Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis. Am J Pathol 2002 0.90
101 CD22 serves as a receptor for soluble IgM. Eur J Immunol 2011 0.89
102 L-selectin dimerization enhances tether formation to properly spaced ligand. J Biol Chem 2002 0.89
103 An L-selectin ligand distinct from P-selectin glycoprotein ligand-1 is expressed on endothelial cells and promotes neutrophil rolling in inflammation. Blood 2008 0.88
104 Cerebroside sulfotransferase deficiency ameliorates L-selectin-dependent monocyte infiltration in the kidney after ureteral obstruction. J Biol Chem 2003 0.87
105 L-selectin is not required for T cell-mediated autoimmune diabetes. J Immunol 2002 0.85
106 CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling. Am J Pathol 2009 0.84
107 Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation. Eur J Immunol 2010 0.84
108 L-selectin and intercellular adhesion molecule-1 regulate the development of Concanavalin A-induced liver injury. J Leukoc Biol 2006 0.84
109 B-lymphocyte depletion for the treatment of multiple sclerosis: now things really get interesting. Expert Rev Neurother 2009 0.83
110 Leukocyte rolling velocities and migration are optimized by cooperative L-selectin and intercellular adhesion molecule-1 functions. J Immunol 2002 0.83
111 The differential role of L-selectin and ICAM-1 in Th1-type and Th2-type contact hypersensitivity. J Invest Dermatol 2010 0.81
112 Bone marrow dendritic cell-mediated regulation of TLR and B cell receptor signaling in B cells. J Immunol 2012 0.79
113 CD19 expression in B cells regulates atopic dermatitis in a mouse model. Am J Pathol 2013 0.79
114 Ultraviolet light exposure suppresses contact hypersensitivity by abrogating endothelial intercellular adhesion molecule-1 up-regulation at the elicitation site. J Immunol 2003 0.79
115 α4β7 Integrin is essential for contact hypersensitivity by regulating migration of T cells to skin. J Allergy Clin Immunol 2010 0.78
116 Establishment of experimental eosinophilic vasculitis by IgE-mediated cutaneous reverse passive arthus reaction. Am J Pathol 2009 0.78
117 Targeting B-cells mitigates autoimmune diabetes in NOD mice: what is plan B? Diabetes 2009 0.78
118 B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals. Int Immunol 2010 0.78
119 [IL-21 induces regulatory B cell differentiation and immunosuppressive effect through cognate interaction with T cells]. Nihon Rinsho Meneki Gakkai Kaishi 2015 0.77
120 Decreased expression levels of CD22 and L-selectin on peripheral blood B lymphocytes from patients with bullous pemphigoid. J Autoimmun 2006 0.77
121 EndoU is a novel regulator of AICD during peripheral B cell selection. J Exp Med 2013 0.76
122 A crucial role of L-selectin in C protein-induced experimental polymyositis in mice. Arthritis Rheumatol 2014 0.75
123 A reevaluation of CD22 expression in human lung cancer. Cancer Res 2014 0.75
124 Heterotropic modulation of selectin affinity by allosteric antibodies affects leukocyte rolling. J Immunol 2014 0.75
125 Humoral autoimmunity in mice overexpressing B cell surface CD19: vital role for MHC class II. Clin Immunol 2005 0.75
126 Introduction: Regulatory B Cell Special Issue-making all the pieces fit. Int Immunol 2015 0.75
127 The Tumor Microenvironment Regulates CD19 and CD20 Immunotherapy for Lymphoma. Cancer J 2015 0.75